ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms (Q37977330)

26 August 2017

ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms (English)

1 reference

26 August 2017

0 references

Guido Rindi

4

0 references

Beata Kos-Kudła

5

object named as

Beata Kos-Kudla

1 reference

ORCID Public Data File 2021

26 August 2017

1 reference

Hironobu Sasano

7

object named as

Hironobu Sasano

1 reference

26 August 2017

Gianfranco Delle Fave

1

1 reference

26 August 2017

Dik J Kwekkeboom

2

1 reference

26 August 2017

Erik Van Cutsem

3

1 reference

26 August 2017

Ulrich Knigge

6

1 reference

26 August 2017

Paola Tomassetti

8

1 reference

26 August 2017

Ramon Salazar

9

1 reference

26 August 2017

Philippe Ruszniewski

10

1 reference

26 August 2017

Barcelona Consensus Conference participants

11

1 reference

26 August 2017

15 February 2012

1 reference

26 August 2017

1 reference

26 August 2017

95

1 reference

26 August 2017

74-87

1 reference

26 August 2017

2

1 reference

Well-differentiated gastric tumors/carcinomas

26 August 2017

1 reference

Well-differentiated duodenal tumor/carcinoma (excluding gastrinomas).

21 January 2018

1 reference

The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification

21 January 2018

1 reference

Duodenal neuroendocrine tumors: Classification, functional syndromes, diagnosis and medical treatment

21 January 2018

1 reference

Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters.

21 January 2018

1 reference

Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior.

21 January 2018

1 reference

Histopathological classification of nonantral gastric endocrine growths in man.

21 January 2018

1 reference

Mucosal argyrophil endocrine cells in pernicious anaemia and upper gastrointestinal carcinoid tumours

21 January 2018

1 reference

Gastroscopic screening in 80 patients with pernicious anaemia

21 January 2018

1 reference

Histopathology of gastric carcinoids: a survey of 42 cases.

21 January 2018

1 reference

Development of type I gastric carcinoid in patients with chronic atrophic gastritis.

21 January 2018

1 reference

Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome

21 January 2018

1 reference

Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature.

21 January 2018

1 reference

Gastric carcinoid tumors in multiple endocrine neoplasia-1 patients with Zollinger-Ellison syndrome can be symptomatic, demonstrate aggressive growth, and require surgical treatment.

21 January 2018

1 reference

Fundic argyrophil carcinoid tumor in a patient with sporadic-type Zollinger-Ellison syndrome

21 January 2018

1 reference

Carcinoid tumors of the stomach

21 January 2018

1 reference

A 5-decade analysis of 13,715 carcinoid tumors

21 January 2018

1 reference

Carcinoid of the ampulla of Vater. Clinical characteristics and morphologic features

21 January 2018

1 reference

Ampullary carcinoid tumors: rationale for an aggressive surgical approach

21 January 2018

1 reference

Carcinoid of the ampulla of Vater

21 January 2018

1 reference

Duodenal somatostatinoma presenting with complete somatostatinoma syndrome

21 January 2018

1 reference

Carcinoid-islet cell tumors of the duodenum. Report of twenty-one cases.

21 January 2018

1 reference

Duodenal and ampullary carcinoid tumors. A report of 12 cases with pathological characteristics, polypeptide content and relation to the MEN I syndrome and von Recklinghausen's disease (neurofibromatosis).

21 January 2018

1 reference

Does the use of routine duodenotomy (DUODX) affect rate of cure, development of liver metastases, or survival in patients with Zollinger-Ellison syndrome?

21 January 2018

1 reference

Current surgical management of Zollinger-Ellison syndrome (ZES) in patients without multiple endocrine neoplasia-type 1 (MEN1).

21 January 2018

1 reference

Advances in evaluation and management of gastrinoma in patients with Zollinger-Ellison syndrome

21 January 2018

1 reference

Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome.

21 January 2018

1 reference

Surgery to cure the Zollinger-Ellison syndrome

21 January 2018

1 reference

Foregut carcinoids: a clinical and biochemical analysis

21 January 2018

1 reference

Duodenal carcinoid tumors: how aggressive should we be?

21 January 2018

1 reference

Atrophic body gastritis patients with enterochromaffin-like cell dysplasia are at increased risk for the development of type I gastric carcinoid.

21 January 2018

1 reference

Relations between circulating gastrin and endocrine cell proliferation in the atrophic gastric fundic mucosa

21 January 2018

1 reference

Development of gastric argyrophil carcinoid tumors in a case of Zollinger-Ellison syndrome with primary hyperparathyroidism during long-term antisecretory treatment

21 January 2018

1 reference

Carcinoid tumors of the duodenum

21 January 2018

1 reference

Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome

21 January 2018

1 reference

Diagnostic uses of radiolabelled somatostatin receptor analogues in gastroenteropancreatic endocrine tumours

21 January 2018

1 reference

Local endoscopic removal of duodenal carcinoid tumors

21 January 2018

1 reference

Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome

21 January 2018

1 reference

Evaluation of (111)In-pentetreotide, (131)I-MIBG and bone scintigraphy in the detection and clinical management of bone metastases in carcinoid disease

21 January 2018

1 reference

Duodenal somatostatinoma: a case report and review of 31 cases with special reference to the relationship between tumor size and metastasis

21 January 2018

1 reference

Duodenal gangliocytic paraganglioma. Report of a case and review of the literature

21 January 2018

1 reference

Primary small-cell neuroendocrine carcinoma of the duodenum - a case report and review of literature

21 January 2018

1 reference

Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems?

21 January 2018

1 reference

Type 1 and 2 gastric carcinoid tumors: long-term follow-up of the efficacy of treatment with a slow-release somatostatin analogue

21 January 2018

1 reference

Long-acting somatostatin analogues are an effective treatment for type 1 gastric carcinoid tumours.

21 January 2018

1 reference

Gastric endocrine tumors type I: treatment with long-acting somatostatin analogs

21 January 2018

1 reference

A carcinoid tumor of the ampulla of Vater treated by endoscopic snare papillectomy.

21 January 2018

1 reference

Peptide receptor radionuclide therapy

21 January 2018

1 reference

Radiolabelled peptides for tumour therapy: current status and future directions. Plenary lecture at the EANM 2002.

21 January 2018

1 reference

Survival and response after peptide receptor radionuclide therapy with [90Y-DOTA0,Tyr3]octreotide in patients with advanced gastroenteropancreatic neuroendocrine tumors

21 January 2018

1 reference

Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors

21 January 2018

1 reference

ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary

21 January 2018

1 reference

Octreotide versus octreotide plus interferon-alpha in endocrine gastroenteropancreatic tumors: a randomized trial

21 January 2018

1 reference

Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors--the International Lanreotide and Interferon Alfa

21 January 2018

1 reference

Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma.

21 January 2018

1 reference

Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms

21 January 2018

1 reference

Neuroendocrine tumours of the duodenum. Clinical aspects, pathomorphology and therapy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000335595

1 reference

26 August 2017

1 reference